GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
GTHX
Delisted
GTHX was delisted on the 17th of September, 2024.
108 hedge funds and large institutions have $270M invested in G1 Therapeutics, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 41 increasing their positions, 35 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
33% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 18
Holders
108
Holding in Top 10
–
Calls
$1.07M
Puts
$1.13M
Top Buyers
| 1 | +$6.75M | |
| 2 | +$3.16M | |
| 3 | +$2.29M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$1.75M |
| 5 |
Rafferty Asset Management
New York
|
+$1.74M |
Top Sellers
| 1 | -$8.77M | |
| 2 | -$3.87M | |
| 3 | -$2.65M | |
| 4 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$2.56M |
| 5 |
Russell Investments Group
London,
United Kingdom
|
-$2.1M |